Clinical Trial Update: Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating I-124 EVuzamitide for cardiac amyloidosis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis

Drugs mentioned

• I-124 EVuzamitide

Snippet

Sponsor: Sharmila Dorbala | Conditions: Cardiac Amyloidosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING